Skip to content

Equine Precision Therapy

Active Private limited companyfounded 2023active for 3 yearsChaussée de Nivelles, Mazy 15, 5032 GemblouxKBO/BCE: BE 0797.728.295

Lifetime

3 annual accounts with figures on one time axis
peak of €142,700 in 2025
€142,700▲ 39.3%
peak of €98,879 in 2025
€98,879▲ 36.2%
peak of €222,668 in 2025
€222,668▲ 79.9%
€190,470▲ 297%
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
14-08-202614 days late
2025micro format
Gross margin from €102,452 to €142,700Result from €72,585 to €98,879Equity from €123,788 to €222,668Debts from €47,963 to €190,470Cash from €126,077 to €200,940

Key points

from the 2025 annual accounts

Equity

€222,668 ▲ 79.9%
€124,0002024€223,0002025

Equity rose in 2025 from €123,788 to €222,668.

Turnover

≈ €350,000 estimated

The micro format states no turnover.

Liquidity

5.52 was 3.38 in 2024

Short-term debts rose from €47,963 to €73,220.

Filings

3 annual accounts 2 late
AprilJune31 JulyOctober202320242025

The 2025 accounts came in latest, 14 days after the end of the period.

Position in the sector

€98,879

Higher net result than 87% of companies in veterinary activities. Sector median €30,839 · 1,633 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Equine Precision Therapy has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Equine Precision Therapy. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 27-01-2023
Director, since 27-01-2023
  • 10 sharesdeed of 31-01-2023
  • 10 sharesdeed of 31-01-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0797728295
Incorporation Founding capital of €2,000, 20 shares · Founded by and · (director) and (director) appointed · published on 31-01-2023 · Gazette deed
First establishment Chaussée de Nivelles, Mazy 15, Gembloux
All 9 events

Comparable companies

same main activity, similar in size and age
Company
Equine Precision Therapy Gembloux €413,138 €142,700 53.9% -
Cabinet Vétérinaire Leboutte Verviers €446,715 €138,706 24.8% -
Dierenartsenpraktijk Vandekeybus Hoogstraten €459,482 €153,874 82.0% -
DierenArtsPraktijk De Sphynx Tremelo €475,117 €149,087 53.0% -
DAP Jacobs Caroline Geetbets €356,818 €136,144 76.5% -
BAUDELET Vet Rochefort €457,434 €147,878 19.0% -
CINAVET Hamois €315,873 €164,494 47.0% -

These companies have the same main activity as Equine Precision Therapy: veterinary services (NACE 75000). They are comparable in size and age: total assets between €316,000 and €475,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 27-01-2023Normal situation
Activity
Veterinary servicesNACE 75000and 1 other
Establishment unit
2.340.966.9205032 Gembloux, since 27-01-2023
Financial year end
31 December
Peppol
Reachable since 29-10-2025
Company details

Annual accounts 2025

€413,138▲ 141%
Filing
Filed on 14-08-2026
Financials

Insights on Equine Precision Therapy

Equine Precision Therapy files the micro format. That format states no turnover. The gross margin rose from €75,098 in 2023 to €142,700 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Equine Precision Therapy

What is the company number of Equine Precision Therapy?
The company number of Equine Precision Therapy is 0797.728.295. The VAT number is the same number with BE in front: BE 0797.728.295.
Where is Equine Precision Therapy based?
The registered office is at Chaussée de Nivelles, Mazy 15, 5032 Gembloux.Company details
What does Equine Precision Therapy do?
According to the KBO register, the main activity is veterinary services (NACE 75000).
What is the legal form of Equine Precision Therapy?
Equine Precision Therapy is a private limited company (BV).
When was Equine Precision Therapy founded?
Equine Precision Therapy was founded on 27-01-2023.
Is Equine Precision Therapy still active?
Yes, Equine Precision Therapy is an active enterprise in the KBO register.
What is the turnover of Equine Precision Therapy?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €142,700 and 2,459 comparable companies of the same size. It probably lies between €240,000 and €550,000. It is a rough estimate.Financials
Is Equine Precision Therapy profitable?
In financial year 2025, Equine Precision Therapy made a profit of €98,879.
Where can I find the annual accounts of Equine Precision Therapy?
Equine Precision Therapy filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Equine Precision Therapy due?
Equine Precision Therapy must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.